Meeting Public Comments

Subcommittee meeting and times are as follows:
Attendance at subcommittee meetings by lobbyists and the public is via zoom or in-person. See agenda for zoom details. Only authenticated users are permitted access.
A bill for an act establishing an excise tax on the sales price of consumable hemp products sold or purchased.(See SF 2417.)
Subcommittee members: Dawson-CH, Dotzler, Driscoll
Date: Wednesday, March 13, 2024
Time: 2:00 PM - 3:00 PM
Location: Room 315
Comments Submitted:
The purpose of comments is to provide information to members of the subcommittee.
Names and comments are public records. Remaining information is considered a confidential record.

03-13-2024
Carl Olsen [Iowans for Medical Marijuana]
After listing to the house debate on HF 2605 last night, I heard CBD come up in three different contexts. I heard three things, all CBD. (1). We call our medical program a CBD program and it has products with 80% THC and 1.5% CBD. How is the public supposed to understand that? Its lie. It was an intentional lie to disguise the intent. (2). Blank Children Hospital recommends Epidiolex off label, which is crazy expensive. (3). Rep. Holt said the hemp program was not meant to replace the medical program, but was meant to allow medical use of CBD. The medical program is titled a CBD program. This is not fair. Rename that medical program to Medical Cannabis like the board has been saying for the past seven years.Get a federal exemption for Medical Cannabis just like the suspension of criminal enforcement in the annual appropriations status for the U.S. Department of Justice, just like the one the U.S. Department of Justice currently has for Schedule I peyote, 21 C.F.R. 1307.31. The board has been asking for that for the past seven years. That board was created for this sole purpose and now the legislature wont listen to it. The cheapest way to make CBD is with hemp, because you made medical CDB illegal under federal tax code, 26 U.S.C. 280E, and Epidiolex is ridiculously expensive. Pathetic.